New Insights into the Role of NLRP3 Inflammasome in Pathogenesis and Treatment of Chronic Obstructive Pulmonary Disease

References

• Barnes PJ. Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med. 2014;35:71–86. doi:10.1016/j.ccm.2013.10.004
   PubMed Web of Science ®Google Scholar
• Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545–1602.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. New anti-inflammatory targets for chronic obstructive pulmonary disease. Nat Rev Drug Discov. 2013;12:543–559. doi:10.1038/nrd4025
   PubMed Web of Science ®Google Scholar
• Adhikari TB, Acharya P, Hogman M, et al. Prevalence of Chronic Obstructive Pulmonary Disease and its Associated Factors in Nepal: findings from a Community-based Household Survey. Int J Chron Obstruct Pulmon Dis. 2020;15:2319–2331. doi:10.2147/COPD.S268110
   PubMed Web of Science ®Google Scholar
• Xie M, Liu X, Cao X, Guo M, Li X. Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017. Respir Res. 2020;21:49. doi:10.1186/s12931-020-1291-8
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Burney PG, Silverman EK, et al. Chronic obstructive pulmonary disease. Nat Rev Dis Primers. 2015;1:15076. doi:10.1038/nrdp.2015.76
   PubMed Web of Science ®Google Scholar
• Brode SK, Ling SC, Chapman KR. Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease. CMAJ. 2012;184:1365–1371. doi:10.1503/cmaj.111749
   PubMed Web of Science ®Google Scholar
• Hobbs BD, de Jong K, Lamontagne M, et al. Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis. Nat Genet. 2017;49:426–432. doi:10.1038/ng.3752
   PubMed Web of Science ®Google Scholar
• Antunes MA, Rocco PR. Elastase-induced pulmonary emphysema: insights from experimental models. An Acad Bras Cienc. 2011;83:1385–1396. doi:10.1590/S0001-37652011005000039
   PubMed Web of Science ®Google Scholar
• Suki B, Bartolak-Suki E, Rocco PRM. Elastase-Induced Lung Emphysema Models in Mice. Methods Mol Biol. 2017;1639:67–75.
   PubMedGoogle Scholar
• Wu W, Chen X, Liu X, Liu C, Lu G. Heliox-Driven Nebulization Has a Positive Effect on the Lung Function in Lipopolysaccharide-Induced Chronic Obstructive Pulmonary Disease Rat Model. Med Sci Monit. 2016;22:4100–4106. doi:10.12659/MSM.896736
   PubMed Web of Science ®Google Scholar
• Lee SY, Cho JH, Cho SS, Bae CS, Kim GY, Park DH. Establishment of a chronic obstructive pulmonary disease mouse model based on the elapsed time after LPS intranasal instillation. Lab Anim Res. 2018;34:1–10. doi:10.5625/lar.2018.34.1.1
   PubMedGoogle Scholar
• Kobayashi S, Fujinawa R, Ota F, et al. A single dose of lipopolysaccharide into mice with emphysema mimics human chronic obstructive pulmonary disease exacerbation as assessed by micro-computed tomography. Am J Respir Cell Mol Biol. 2013;49:971–977. doi:10.1165/rcmb.2013-0074OC
   PubMed Web of Science ®Google Scholar
• Mudway IS, Kelly FJ. Ozone and the lung: a sensitive issue. Mol Aspects Med. 2000;21:1–48. doi:10.1016/S0098-2997(00)00003-0
   PubMedGoogle Scholar
• Becker S, Madden MC, Newman SL, Devlin RB, Koren HS. Modulation of human alveolar macrophage properties by ozone exposure in vitro. Toxicol Appl Pharmacol. 1991;110:403–415. doi:10.1016/0041-008X(91)90042-D
   PubMed Web of Science ®Google Scholar
• Manzer R, Dinarello CA, McConville G, Mason RJ. Ozone exposure of macrophages induces an alveolar epithelial chemokine response through IL-1alpha. Am J Respir Cell Mol Biol. 2008;38:318–323. doi:10.1165/rcmb.2007-0250OC
   PubMed Web of Science ®Google Scholar
• Halonen JI, Lanki T, Yli-Tuomi T, Kulmala M, Tiittanen P, Pekkanen J. Urban air pollution, and asthma and COPD hospital emergency room visits. Thorax. 2008;63:635–641. doi:10.1136/thx.2007.091371
   PubMed Web of Science ®Google Scholar
• Wang M, Aaron CP, Madrigano J, et al. Association Between Long-term Exposure to Ambient Air Pollution and Change in Quantitatively Assessed Emphysema and Lung Function. JAMA. 2019;322:546–556. doi:10.1001/jama.2019.10255
   PubMed Web of Science ®Google Scholar
• Russell KE, Chung KF, Clarke CJ, et al. The MIF Antagonist ISO-1 Attenuates Corticosteroid-Insensitive Inflammation and Airways Hyperresponsiveness in an Ozone-Induced Model of COPD. PLoS One. 2016;11:e0146102. doi:10.1371/journal.pone.0146102
   PubMed Web of Science ®Google Scholar
• Wright JL, Cosio M, Churg A. Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2008;295:L1–15. doi:10.1152/ajplung.90200.2008
   PubMed Web of Science ®Google Scholar
• Churg A, Wang RD, Tai H, et al. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release. Am J Respir Crit Care Med. 2003;167:1083–1089. doi:10.1164/rccm.200212-1396OC
   PubMed Web of Science ®Google Scholar
• Guo H, Callaway JB, Ting JP. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21:677–687. doi:10.1038/nm.3893
   PubMed Web of Science ®Google Scholar
• Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19:477–489. doi:10.1038/s41577-019-0165-0
   PubMed Web of Science ®Google Scholar
• Bakker PJ, Butter LM, Claessen N, et al. A tissue-specific role for Nlrp3 in tubular epithelial repair after renal ischemia/reperfusion. Am J Pathol. 2014;184:2013–2022. doi:10.1016/j.ajpath.2014.04.005
   PubMed Web of Science ®Google Scholar
• Gwyer Findlay E, Hussell T. Macrophage-mediated inflammation and disease: a focus on the lung. Mediators Inflamm. 2012;2012:140937. doi:10.1155/2012/140937
   PubMed Web of Science ®Google Scholar
• Peeters PM, Perkins TN, Wouters EF, Mossman BT, Reynaert NL. Silica induces NLRP3 inflammasome activation in human lung epithelial cells. Part Fibre Toxicol. 2013;10:3. doi:10.1186/1743-8977-10-3
   PubMed Web of Science ®Google Scholar
• Faner R, Sobradillo P, Noguera A, et al. The inflammasome pathway in stable COPD and acute exacerbations. ERJ Open Res. 2016;2:2.
   PubMedGoogle Scholar
• Nachmias N, Langier S, Brzezinski RY, et al. NLRP3 inflammasome activity is upregulated in an in-vitro model of COPD exacerbation. PLoS One. 2019;14:e0214622. doi:10.1371/journal.pone.0214622
   PubMed Web of Science ®Google Scholar
• Wang H, Lv C, Wang S, Ying H, Weng Y, Yu W. NLRP3 Inflammasome Involves in the Acute Exacerbation of Patients with Chronic Obstructive Pulmonary Disease. Inflammation. 2018;41:1321–1333. doi:10.1007/s10753-018-0780-0
   PubMed Web of Science ®Google Scholar
• Singh B, Arora S, Khanna V. Association of severity of COPD with IgE and interleukin-1 beta. Monaldi Arch Chest Dis. 2010;73:86–87.
   PubMedGoogle Scholar
• Damera G, Pham TH, Zhang J, et al. A Sputum Proteomic Signature That Associates with Increased IL-1beta Levels and Bacterial Exacerbations of COPD. Lung. 2016;194:363–369. doi:10.1007/s00408-016-9877-0
   PubMed Web of Science ®Google Scholar
• Kuschner WG, D’Alessandro A, Wong H, Blanc PD. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J. 1996;9:1989–1994. doi:10.1183/09031936.96.09101989
   PubMed Web of Science ®Google Scholar
• Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J. 2001;34:50s–59s. doi:10.1183/09031936.01.00229701
   Google Scholar
• Lappalainen U, Whitsett JA, Wert SE, Tichelaar JW, Bry K. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol. 2005;32:311–318. doi:10.1165/rcmb.2004-0309OC
   PubMed Web of Science ®Google Scholar
• Doz E, Noulin N, Boichot E, et al. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol. 2008;180:1169–1178. doi:10.4049/jimmunol.180.2.1169
   PubMed Web of Science ®Google Scholar
• Botelho FM, Bauer CM, Finch D, et al. IL-1alpha/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice. PLoS One. 2011;6:e28457. doi:10.1371/journal.pone.0028457
   PubMed Web of Science ®Google Scholar
• Pauwels NS, Bracke KR, Dupont LL, et al. Role of IL-1alpha and the Nlrp3/caspase-1/IL-1beta axis in cigarette smoke-induced pulmonary inflammation and COPD. Eur Respir J. 2011;38:1019–1028. doi:10.1183/09031936.00158110
   PubMed Web of Science ®Google Scholar
• Kang MJ, Homer RJ, Gallo A, et al. IL-18 is induced and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation. J Immunol. 2007;178:1948–1959. doi:10.4049/jimmunol.178.3.1948
   PubMed Web of Science ®Google Scholar
• Petersen AM, Penkowa M, Iversen M, et al. Elevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary disease. Lung. 2007;185:161–171. doi:10.1007/s00408-007-9000-7
   PubMed Web of Science ®Google Scholar
• Hoshino T, Kato S, Oka N, et al. Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13. Am J Respir Crit Care Med. 2007;176:49–62. doi:10.1164/rccm.200603-316OC
   PubMed Web of Science ®Google Scholar
• Franklin BS, Bossaller L, De Nardo D, et al. The adaptor ASC has extracellular and ‘prionoid’ activities that propagate inflammation. Nat Immunol. 2014;15:727–737. doi:10.1038/ni.2913
   PubMed Web of Science ®Google Scholar
• Eltom S, Stevenson CS, Rastrick J, et al. P2X7 receptor and caspase 1 activation are central to airway inflammation observed after exposure to tobacco smoke. PLoS One. 2011;6:e24097. doi:10.1371/journal.pone.0024097
   PubMed Web of Science ®Google Scholar
• Churg A, Zhou S, Wang X, Wang R, Wright JL. The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling. Am J Respir Cell Mol Biol. 2009;40:482–490. doi:10.1165/rcmb.2008-0038OC
   PubMed Web of Science ®Google Scholar
• Ferhani N, Letuve S, Kozhich A, et al. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181:917–927. doi:10.1164/rccm.200903-0340OC
   PubMed Web of Science ®Google Scholar
• Mortaz E, Folkerts G, Nijkamp FP, Henricks PA. ATP and the pathogenesis of COPD. Eur J Pharmacol. 2010;638:1–4. doi:10.1016/j.ejphar.2010.04.019
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138:16–27. doi:10.1016/j.jaci.2016.05.011
   PubMed Web of Science ®Google Scholar
• Durham AL, Adcock IM. The relationship between COPD and lung cancer. Lung Cancer. 2015;90:121–127. doi:10.1016/j.lungcan.2015.08.017
   PubMed Web of Science ®Google Scholar
• Harijith A, Ebenezer DL, Natarajan V. Reactive oxygen species at the crossroads of inflammasome and inflammation. Front Physiol. 2014;5:352. doi:10.3389/fphys.2014.00352
   PubMed Web of Science ®Google Scholar
• Wattanachayakul P, Rujirachun P, Charoenngam N, Ungprasert P. Chronic obstructive pulmonary disease (COPD) is associated with a higher level of serum uric acid. A systematic review and meta-analysis. Adv Respir Med. 2020;88:215–222. doi:10.5603/ARM.2020.0119
   PubMed Web of Science ®Google Scholar
• Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237–241. doi:10.1038/nature04516
   PubMed Web of Science ®Google Scholar
• Braga TT, Forni MF, Correa-Costa M, et al. Soluble Uric Acid Activates the NLRP3 Inflammasome. Sci Rep. 2017;7:39884. doi:10.1038/srep39884
   PubMed Web of Science ®Google Scholar
• Wanderer AA. Interleukin-1beta targeted therapy in severe persistent asthma (SPA) and chronic obstructive pulmonary disease (COPD): proposed similarities between biphasic pathobiology of SPA/COPD and ischemia-reperfusion injury. Isr Med Assoc J. 2008;10:837–842.
   PubMed Web of Science ®Google Scholar
• Uh ST, Koo SM, Kim Y, et al. The activation of NLRP3-inflammsome by stimulation of diesel exhaust particles in lung tissues from emphysema model and RAW 264.7 cell line. Korean J Intern Med. 2017;32:865–874. doi:10.3904/kjim.2016.033
   PubMed Web of Science ®Google Scholar
• Zhao J, Li M, Wang Z, et al. Role of PM2.5 in the development and progression of COPD and its mechanisms. Respir Res. 2019;20:120. doi:10.1186/s12931-019-1081-3
   PubMed Web of Science ®Google Scholar
• Zheng R, Tao L, Jian H, et al. NLRP3 inflammasome activation and lung fibrosis caused by airborne fine particulate matter. Ecotoxicol Environ Saf. 2018;163:612–619. doi:10.1016/j.ecoenv.2018.07.076
   PubMed Web of Science ®Google Scholar
• Tian L, Yan J, Li K, et al. Ozone exposure promotes pyroptosis in rat lungs via the TLR2/4-NF-kappaB-NLRP3 signaling pathway. Toxicology. 2021;450:152668. doi:10.1016/j.tox.2020.152668
   PubMed Web of Science ®Google Scholar
• Li C, Zhihong H, Wenlong L, et al. The Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain-Containing 3 Inflammasome Regulates Bronchial Epithelial Cell Injury and Proapoptosis after Exposure to Biomass Fuel Smoke. Am J Respir Cell Mol Biol. 2016;55:815–824. doi:10.1165/rcmb.2016-0051OC
   PubMed Web of Science ®Google Scholar
• Wagner U, Staats P, Fehmann HC, Fischer A, Welte T, Groneberg DA. Analysis of airway secretions in a model of sulfur dioxide induced chronic obstructive pulmonary disease (COPD). J Occup Med Toxicol. 2006;1:12. doi:10.1186/1745-6673-1-12
   PubMed Web of Science ®Google Scholar
• Yang L, Zhang H, Chen P. Sulfur dioxide attenuates sepsis-induced cardiac dysfunction via inhibition of NLRP3 inflammasome activation in rats. Nitric Oxide. 2018;81:11–20. doi:10.1016/j.niox.2018.09.005
   PubMed Web of Science ®Google Scholar
• Hnizdo E, Vallyathan V. Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence. Occup Environ Med. 2003;60:237–243. doi:10.1136/oem.60.4.237
   PubMed Web of Science ®Google Scholar
• Peeters PM, Eurlings IM, Perkins TN, et al. Silica-induced NLRP3 inflammasome activation in vitro and in rat lungs. Part Fibre Toxicol. 2014;11:58. doi:10.1186/s12989-014-0058-0
   PubMed Web of Science ®Google Scholar
• Wu R, Hogberg J, Adner M, Ramos-Ramirez P, Stenius U, Zheng H. Crystalline silica particles cause rapid NLRP3-dependent mitochondrial depolarization and DNA damage in airway epithelial cells. Part Fibre Toxicol. 2020;17:39. doi:10.1186/s12989-020-00370-2
   PubMed Web of Science ®Google Scholar
• Hedbrant A, Andersson L, Bryngelsson IL, et al. Quartz Dust Exposure Affects NLRP3 Inflammasome Activation and Plasma Levels of IL-18 and IL-1Ra in Iron Foundry Workers. Mediators Inflamm. 2020;2020:8490908. doi:10.1155/2020/8490908
   PubMed Web of Science ®Google Scholar
• Shamssain MH. Pulmonary function and symptoms in workers exposed to wood dust. Thorax. 1992;47:84–87. doi:10.1136/thx.47.2.84
   PubMed Web of Science ®Google Scholar
• Mandryk J, Alwis KU, Hocking AD. Work-related symptoms and dose-response relationships for personal exposures and pulmonary function among woodworkers. Am J Ind Med. 1999;35:481–490. doi:10.1002/(SICI)1097-0274(199905)35:5<481::AID-AJIM5>3.0.CO;2-N
   PubMed Web of Science ®Google Scholar
• Sethi S. Infection as a comorbidity of COPD. Eur Respir J. 2010;35:1209–1215. doi:10.1183/09031936.00081409
   PubMed Web of Science ®Google Scholar
• Jain NK. Chronic obstructive pulmonary disease and tuberculosis. Lung India. 2017;34:468–469.
   PubMedGoogle Scholar
• Dorhoi A, Nouailles G, Jorg S, et al. Activation of the NLRP3 inflammasome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis. Eur J Immunol. 2012;42:374–384. doi:10.1002/eji.201141548
   PubMed Web of Science ®Google Scholar
• Segovia J, Sabbah A, Mgbemena V, et al. TLR2/MyD88/NF-kappaB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS One. 2012;7:e29695. doi:10.1371/journal.pone.0029695
   PubMed Web of Science ®Google Scholar
• Kuriakose T, Man SM, Malireddi RK, et al. ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci Immunol. 2016;5:1.
   Google Scholar
• Liu T, Zhou YT, Wang LQ, et al. NOD-like receptor family, pyrin domain containing 3 (NLRP3) contributes to inflammation, pyroptosis, and mucin production in human airway epithelium on rhinovirus infection. J Allergy Clin Immunol. 2019;144:777–787 e779.
   PubMed Web of Science ®Google Scholar
• Sandford AJ, Weir TD, Pare PD. Genetic risk factors for chronic obstructive pulmonary disease. Eur Respir J. 1997;10:1380–1391. doi:10.1183/09031936.97.10061380
   PubMed Web of Science ®Google Scholar
• Hall R, Hall IP, Sayers I. Genetic risk factors for the development of pulmonary disease identified by genome-wide association. Respirology. 2019;24:204–214. doi:10.1111/resp.13436
   PubMed Web of Science ®Google Scholar
• Ebrahimi T, Rust M, Kaiser SN, et al. alpha1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid beta1-42-stimulated murine astrocytes. J Neuroinflammation. 2018;15:282. doi:10.1186/s12974-018-1319-x
   PubMed Web of Science ®Google Scholar
• Couillin I, Vasseur V, Charron S, et al. IL-1R1/MyD88 signaling is critical for elastase-induced lung inflammation and emphysema. J Immunol. 2009;183:8195–8202. doi:10.4049/jimmunol.0803154
   PubMed Web of Science ®Google Scholar
• Wang L, Lei W, Zhang S, Yao L. MCC950, a NLRP3 inhibitor, ameliorates lipopolysaccharide-induced lung inflammation in mice. Bioorg Med Chem. 2021;30:115954. doi:10.1016/j.bmc.2020.115954
   PubMed Web of Science ®Google Scholar
• Yang JW, Mao B, Tao RJ, et al. Corticosteroids alleviate lipopolysaccharide-induced inflammation and lung injury via inhibiting NLRP3-inflammasome activation. J Cell Mol Med. 2020;24:12716–12725. doi:10.1111/jcmm.15849
   PubMed Web of Science ®Google Scholar
• Bauer AK, Rondini EA, Hummel KA, et al. Identification of candidate genes downstream of TLR4 signaling after ozone exposure in mice: a role for heat-shock protein 70. Environ Health Perspect. 2011;119:1091–1097. doi:10.1289/ehp.1003326
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen Q, Jiao F, et al. Histone deacetylase 2 regulates ULK1 mediated pyroptosis during acute liver failure by the K68 acetylation site. Cell Death Dis. 2021;12:55.
   PubMed Web of Science ®Google Scholar
• Wiegman CH, Li F, Clarke CJ, et al. A comprehensive analysis of oxidative stress in the ozone-induced lung inflammation mouse model. Clin Sci (Lond). 2014;126:425–440. doi:10.1042/CS20130039
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 2018;281:8–27. doi:10.1111/imr.12621
   PubMed Web of Science ®Google Scholar
• Xu M, Wang L, Wang M, et al. Mitochondrial ROS and NLRP3 inflammasome in acute ozone-induced murine model of airway inflammation and bronchial hyperresponsiveness. Free Radic Res. 2019;53:780–790. doi:10.1080/10715762.2019.1630735
   PubMed Web of Science ®Google Scholar
• Beckett EL, Stevens RL, Jarnicki AG, et al. A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis. J Allergy Clin Immunol. 2013;131:752–762. doi:10.1016/j.jaci.2012.11.053
   PubMed Web of Science ®Google Scholar
• Yang W, Ni H, Wang H, Gu H. NLRP3 inflammasome is essential for the development of chronic obstructive pulmonary disease. Int J Clin Exp Pathol. 2015;8:13209–13216.
   PubMed Web of Science ®Google Scholar
• Kumar M, Phougat N, Ruhil S, Dhankhar S, Balhara M, Chhillar AK. Genomics of Chronic Obstructive Pulmonary Disease (COPD); Exploring the SNPs of Protease-Antiprotease Pathway. Curr Genomics. 2013;14:204–213. doi:10.2174/1389202911314030006
   PubMed Web of Science ®Google Scholar
• Baykara O, Tomekce Taskiran NB, Soyyigit S, Buyru N. IL-1beta polymorphism in COPD patients in Turkish population. Tuberk Toraks. 2017;65:90–96. doi:10.5578/tt.52778
   PubMedGoogle Scholar
• Ishii T, Matsuse T, Teramoto S, et al. Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD. Respir Med. 2000;94:847–851. doi:10.1053/rmed.2000.0808
   PubMed Web of Science ®Google Scholar
• Xie ZK, Huang QP, Huang J, Xie ZF. Association between the IL1B, IL1RN polymorphisms and COPD risk: a meta-analysis. Sci Rep. 2014;4:6202. doi:10.1038/srep06202
   PubMed Web of Science ®Google Scholar
• Wang YS, Liu L, Xu XY, et al. Association of interleukin-1beta −511C/T promoter polymorphism with COPD risk: a meta-analysis. Genet Mol Res. 2015;14:4477–4484. doi:10.4238/2015.May.4.5
   PubMedGoogle Scholar
• Shukla RK, Kant S, Bhattacharya S, Mittal B. Association of cytokine gene polymorphisms in patients with chronic obstructive pulmonary disease. Oman Med J. 2012;27:285–290. doi:10.5001/omj.2012.71
   PubMedGoogle Scholar
• Lee JM, Kang YR, Park SH, et al. Polymorphisms in interleukin-1B and its receptor antagonist genes and the risk of chronic obstructive pulmonary disease in a Korean population: a case-control study. Respir Med. 2008;102:1311–1320. doi:10.1016/j.rmed.2008.03.026
   PubMed Web of Science ®Google Scholar
• Wang J, Liu X, Xie J, Xu Y. Association of interleukin-18 promoter polymorphisms with chronic obstructive pulmonary disease in male smokers. Int J Immunogenet. 2013;40:204–208. doi:10.1111/iji.12014
   PubMed Web of Science ®Google Scholar
• Hernandez ML, Mills K, Almond M, et al. IL-1 receptor antagonist reduces endotoxin-induced airway inflammation in healthy volunteers. J Allergy Clin Immunol. 2015;135:379–385.
   PubMed Web of Science ®Google Scholar
• Calverley PMA, Sethi S, Dawson M, et al. A randomised, placebo-controlled trial of anti-interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease. Respir Res. 2017;18:153. doi:10.1186/s12931-017-0633-7
   PubMed Web of Science ®Google Scholar
• Bucher H, Mang S, Keck M, et al. Neutralization of both IL-1alpha/IL-1beta plays a major role in suppressing combined cigarette smoke/virus-induced pulmonary inflammation in mice. Pulm Pharmacol Ther. 2017;44:96–105. doi:10.1016/j.pupt.2017.03.008
   PubMed Web of Science ®Google Scholar
• Sichelstiel A, Yadava K, Trompette A, et al. Targeting IL-1beta and IL-17A driven inflammation during influenza-induced exacerbations of chronic lung inflammation. PLoS One. 2014;9:e98440. doi:10.1371/journal.pone.0098440
   PubMed Web of Science ®Google Scholar
• Global Health Data Exchange. Prevalence of chronic obstructive pulmonary disease (COPD). Available from: http://ghdx.healthdata.org/search/site/COPD. Accessed August 20, 2021.
   Google Scholar